681 related articles for article (PubMed ID: 1081991)
1. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
[TBL] [Abstract][Full Text] [Related]
2. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
5. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and biological studies in the Bernard-Soulier syndrome (author's transl)].
Tobelem G
Nouv Rev Fr Hematol (1978); 1976; 16(3):407-11. PubMed ID: 1087721
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
9. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
11. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.
Cohen I; Potter EV; Glaser T; Entwistle R; Davis L; Chediak J; Anderson B
J Lab Clin Med; 1981 Jan; 97(1):134-40. PubMed ID: 6969768
[TBL] [Abstract][Full Text] [Related]
13. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
14. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
15. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
Bryckaert MC; Pietu G; Ruan C; Tobelem G; Girma JP; Meyer D; Larrieu MJ; Caen JP
J Lab Clin Med; 1985 Oct; 106(4):393-400. PubMed ID: 2931492
[TBL] [Abstract][Full Text] [Related]
16. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
Scott JP; Montgomery RR
Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
[TBL] [Abstract][Full Text] [Related]
17. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.
Caen JP; Nurden AT; Jeanneau C; Michel H; Tobelem G; Levy-Toledano S; Sultan Y; Valensi F; Bernard J
J Lab Clin Med; 1976 Apr; 87(4):586-96. PubMed ID: 1083883
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
Gralnick HR; Williams SB; Shafer BC; Corash L
Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
[TBL] [Abstract][Full Text] [Related]
20. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder.
Miller JL; Castella A
Blood; 1982 Sep; 60(3):790-4. PubMed ID: 6286015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
